INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹10 Cr | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.97 Cr |
| Mar2022 | ₹8.10 Cr |
| Mar2021 | ₹5.27 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | -2.66 | |
| Mar2024 | ₹11 Cr | 19.34 | |
| Mar2023 | ₹8.97 Cr | 10.73 | |
| Mar2022 | ₹8.10 Cr | 53.68 | |
| Mar2021 | ₹5.27 Cr | - | |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹151.2 Cr | -3.1% | -6% | -43.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,611.5 Cr | -9.2% | -5.2% | -32.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,317.0 Cr | 0.8% | -0.8% | 10% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,359.4 Cr | 3% | 2.4% | 23.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹878.1 Cr | -2.5% | -5.6% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹516.4 Cr | -1.5% | 7.2% | -10.9% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.1% |
-6% |
-43.8% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses